These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34121413)

  • 1. MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport.
    George RT; Abuhatzira L; Stoughton SM; Karathanasis SK; She D; Jin C; Buss NAPS; Bakker-Arkema R; Ongstad EL; Koren M; Hirshberg B
    J Am Heart Assoc; 2021 Jul; 10(13):e014572. PubMed ID: 34121413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
    Bonaca MP; Morrow DA; Bergmark BA; Berg DD; Lima JAC; Hoffmann U; Kato Y; Lu MT; Kuder J; Murphy SA; Spinar J; Oude Ophuis T; Kiss RG; Lopez-Sendon J; Averkov O; Wheatcroft SB; Kubica J; Carlos Nicolau J; Furtado RHM; Abuhatzira L; Hirshberg B; Omar SA; Vavere AL; Chang YT; George RT; Sabatine MS
    Circulation; 2022 Sep; 146(12):907-916. PubMed ID: 36039762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design.
    Bonaca MP; George RT; Morrow DA; Bergmark BA; Park JG; Abuhatzira L; Vavere AL; Karathanasis SK; Jin C; She D; Hirshberg B; Hsia J; Sabatine MS
    Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):243-252. PubMed ID: 33493256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial.
    Tricoci P; D'Andrea DM; Gurbel PA; Yao Z; Cuchel M; Winston B; Schott R; Weiss R; Blazing MA; Cannon L; Bailey A; Angiolillo DJ; Gille A; Shear CL; Wright SD; Alexander JH
    J Am Heart Assoc; 2015 Aug; 4(8):e002171. PubMed ID: 26307570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects.
    Gille A; Easton R; D'Andrea D; Wright SD; Shear CL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2106-14. PubMed ID: 24969776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol produces dose-dependent antiatherogenic and atherogenic plasma lipoprotein responses.
    Hojnacki JL; Cluette-Brown JE; Deschenes RN; Mulligan JJ; Osmolski TV; Rencricca NJ; Barboriak JJ
    Proc Soc Exp Biol Med; 1992 May; 200(1):67-77. PubMed ID: 1570359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans.
    Reyes-Soffer G; Matveyenko A; Lignos J; Matienzo N; Santos Baez LS; Hernandez-Ono A; Yung L; Nandakumar R; Singh SA; Aikawa M; George R; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1407-1418. PubMed ID: 38695168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.
    Amar MJ; Shamburek RD; Vaisman B; Knapper CL; Foger B; Hoyt RF; Santamarina-Fojo S; Brewer HB; Remaley AT
    Metabolism; 2009 Apr; 58(4):568-75. PubMed ID: 19303980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
    Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A
    Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.
    Rousset X; Vaisman B; Auerbach B; Krause BR; Homan R; Stonik J; Csako G; Shamburek R; Remaley AT
    J Pharmacol Exp Ther; 2010 Oct; 335(1):140-8. PubMed ID: 20605907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.
    Ozturk OH; Can Y; Yonden Z; Motor S; Oktay G; Kaya H; Aslan M
    Lipids; 2013 Dec; 48(12):1217-26. PubMed ID: 24113910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecithin--cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice.
    Agorastos J; Fox C; Harry DS; McIntyre N
    Clin Sci Mol Med; 1978 Apr; 54(4):369-79. PubMed ID: 205385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis.
    Fernandez-Bravo S; Canyelles M; Martín-Blázquez A; Borràs C; Nuñez-Borque E; Palacio-García L; Rodríguez Del Rio P; Betancor D; Gómez-López A; Sabaté Brescó M; Laguna JJ; Méndez-Barbero N; Rotllan N; Escolà-Gil JC; Esteban V
    J Allergy Clin Immunol; 2024 Sep; 154(3):827-832. PubMed ID: 38718948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
    Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease.
    Ruff CT; Koren MJ; Grimsby J; Rosenbaum AI; Tu X; Karathanasis SK; Falloon J; Hsia J; Guan Y; Conway J; Tsai LF; Hummer BT; Hirshberg B; Kuder JF; Murphy SA; George RT; Sabatine MS
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):3005-3014. PubMed ID: 34706556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.
    Asztalos BF; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2007-2015. PubMed ID: 30002062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.